Expression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial Cells

BACKGROUND: The chemokine CCL20 and its receptor CCR6 are putative drug targets in inflammatory bowel disease, and CCL20 is a novel IBD predilection gene. Previous findings on the CCL20 response in these diseases are divergent. This study was undertaken to examine CCL20 and CCR6 during active and in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Skovdahl, Helene Kolstad, Granlund, Atle van Beelen, Østvik, Ann Elisabet, Bruland, Torunn, Bakke, Ingunn, Torp, Sverre Helge, Damås, Jan Kristian, Sandvik, Arne Kristian
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4633243/
https://ncbi.nlm.nih.gov/pubmed/26536229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0141710
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados